Publications by authors named "Johannes B Vogel"
Aim: Over recent years, therapy options and strategies for type 2 diabetes mellitus (T2DM) have developed substantially. This study investigated glucose-lowering treatment in patients with high cardiovascular risk over three decades.
Materials And Methods: A total of 2158 patients undergoing elective coronary angiography at a tertiary care hospital in Europe were included in three sequential observational studies (OS): OS1 (1999-2000; n = 672), OS2 (2005-2008; n = 1005) and OS3 (2022-2023; n = 481).
Article Synopsis
- A standardized medication plan (MPlan) is essential for improving medication safety and adherence, especially during transitions in patient care, but Austria currently lacks such standardization.
- In a study involving 512 patients undergoing elective coronary angiography, only 55.1% had a medication document (MDoc) at hospital admission, with many missing crucial information and a significant portion lacking MDocs altogether.
- A high discrepancy rate of 64.4% was found between the MPlans and patients' actual medications, indicating potential risks to the effectiveness and safety of their treatment regimens.
Background And Aim: Guidelines on dyslipidemia and lipid-lowering therapy (LLT) over the years recommend lower low-density lipoprotein cholesterol (LDL-C) goals by more intense therapy. Nevertheless, LDL‑C has increased in the general population. Real-world trends of LLT medication as well as of LDL‑C levels in cardiovascular high-risk patients are unclear.
View Article and Find Full Text PDF